https://www.zonebourse.com/cours/action/NOVARTIS-AG-9364983/actualite/Novartis-essuie-un-echec-avec-le-canakinumab-contre-le-Covid-19-31704956/?utm_source=telegram&utm_medium=social&utm_campaign=share